Skip to content

Construction and empirical study of nutritional management program for lung cancer radiotherapy patients based on ORTCC model

Construction and empirical study of nutritional management program for lung cancer radiotherapy patients based on ORTCC model

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085977
Enrollment
Unknown
Registered
2024-06-21
Start date
2024-06-21
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing radiotherapy for lung cancer

Interventions

Control group:Routine nutritional management regimen
Research Group:Implement a nutritional management program based on the theoretical model of ORTCC

Sponsors

The Second Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with lung cancer by histopathological pathology; (2) Patients receiving radiotherapy for lung cancer or concurrent adjuvant chemotherapy during radiotherapy; (3) Patients who are conscious, have no barriers to language communication and can complete cooperation; (4) The patient voluntarily participates and signs the informed consent form; (5) Age 18~85 years old; (6) Estimated survival is greater than 6 months

Exclusion criteria

Exclusion criteria: (1) Patients with severe dysfunction of important organs such as heart, liver, and kidneys; (2) Those who do not follow the guidelines for radiotherapy or stop radiotherapy without authorization; (3) Patients with mental illness; (4) Patients with other primary malignant tumors; (5) critically ill patients; (6) Patients with severe digestive system diseases and various metabolic diseases (such as: diabetes, hyperuricemia, hyperlipidemia, hyperthyroidism, hypothyroidism, etc.).

Design outcomes

Primary

MeasureTime frame
albumin;Prealbumin;haemoglobin;platelet;grip strength;Upper arm circumference;Calf circumference;

Secondary

MeasureTime frame
Tumor Quality of Life (EORTC QLQ-C30 V3.0) Scale score;Incidence of adverse effects of radiotherapy;Total length of hospital stay;

Countries

China

Contacts

Public ContactLuo Lu Wen

The Second Affiliated Hospital of Zunyi Medical University

1742589306@qq.com+86 136 3120 4374

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026